Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Jun, 2014 | Pages:
82 | Publisher: Grand View Research
Industry: Healthcare | Report Format: Electronic (PDF)
The global market for artificial organ and bionics is expected to reach USD 38.75 billion by 2020 at an estimated CAGR of 9.3% from 2014 to 2020. Increasing prevalence of acute renal failure and renal disorders due to lifestyle habits such as excessive alcohol consumption and growing geriatric population base causing a rise in organ failure rates is expected to serve this market as a high impact rendering driver. In addition, growing incidence rates of accidents is expected to boost the demand for organ transplants, thus increasing demand for artificial organ. Artificial kidney dominated the global market in 2013, with revenue estimated at over USD 12.21 billion; demand is expected grow due to the increasing chronic kidney patients. Artificial liver is the fastest growing market segment, at an estimated CAGR of 11.0% from 2014 to 2020.
Further key findings from the study suggest:
Brain bionics in the medical bionics market held the largest share of revenue for the year 2013 and the market is expected to grow at an estimated CAGR of 40.0%.The presence of high unmet medical needs in neurology disease segment coupled with expensive treatment procedures is expected to drive the market for brain bionics. Exoskeleton is the fastest growing segment and is expected to grow at a CAGR of 16.0% from 2014 to 2020.
North America was the largest regional market in 2013, accounting for over 42.0% of global revenue due to the increasing population and awareness among the patients and the players.
Asia Pacific is the fastest growing market and is expected to grow at a CAGR of 11.0% from 2014 to 2020 on account of rising demand due to the improvement in healthcare facilities, medical tourism and others.Increasing income levels and healthcare expenditure is expected to interest of the players' in the emerging markets.
Key industry participants include Abiomed Inc., Asahi Kasei Kuraray Medical Co. Ltd., Thoratec Corporation, WorldHeart Corp., Gambro AB and others.
For the purpose of this study, Grand View Research has segmented the global artificial organ and bionics market on the basis of product, technology and region:
Artificial Organ Product Outlook
Artificial organs
Total artificial heart
Artificial liver
Artificial pancreas
Artificial lungs
Artificial kidney
Bionics
Cochlear implants
Exoskeletons
Cardiac bionics
Heart valves
Biological tissue valves
Mechanical valves
Transcatheter heart valves
Ventricular assist device
Bionic limbs
Bionic legs
Bionic hands
Brain bionics
Deep brain stimulators
Spinal cord stimulators
Vagus nerves stimulators
Vision bionics
Artificial Organ Technology Outlook
Mechanical bionics
Electronic bionics
Artificial Organ Regional Outlook
North America
Europe
Asia Pacific
RoW
Table of Contents
Chapter 1. Executive Summary 1.1. Artificial organ- Industry Summary & Critical Success Factors (CSFs) Chapter 2. Artificial organ Industry Outlook 2.1. Market Segmentation 2.2. Market Size and Growth Prospects 2.3. Artificial organ Market Dynamics 2.3.1. Market Driver Analysis 2.3.2. Market Restraint Analysis 2.4. Key Opportunities Prioritized 2.5. Industry Analysis - Porter's 2.6. Artificial organ- Company Market Share Analysis, 2013 2.7. Artificial organ market PESTEL Analysis, 2013 Chapter 3. Artificial organ Product Outlook 3.1. Artificial organs 3.1.1. Global artificial organ demand, (USD Million), 2012 - 2020 3.1.1.1. Global total artificial heart demand, (USD Million), 2012 - 2020 3.1.1.2. Global artificial pancreas demand, (USD Million), 2012 - 2020 3.1.1.3. Global artificial liver demand, (USD Million), 2012 - 2020 3.1.1.4. Global artificial lungs heart demand, (USD Million), 2012 - 2020 3.1.1.5. Global artificial kidney heart demand, (USD Million), 2012 - 2020 3.2. Bionic 3.2.1. Global Bionic demand, (USD Million), 2012 - 2020 3.2.1.1. Global Cochlear implants demand, (USD Million), 2012 - 2020 3.2.1.2. Global Cardiac Bionic demand, (USD Million), 2012 - 2020 3.2.1.3. Global Ventricular assist device demand, (USD Million), 2012 - 2020 3.2.1.4. Global Heart valves demand, (USD Million), 2012 - 2020 3.2.1.5. Global Mechanical valves demand, (USD Million), 2012 - 2020 3.2.1.6. Global Biological tissue valves demand, (USD Million), 2012 - 2020 3.2.1.7. Global Transcatheter heart valves demand, (USD Million), 2012 - 2020 3.2.1.8. Global Brain bionics demand, (USD Million), 2012 - 2020 3.2.1.9. Global Spinal cord stimulators demand, (USD Million), 2012 - 2020 3.2.1.10. Global Deep brain stimulators demand, (USD Million), 2012 - 2020 3.2.1.11. Global Vagus nerve stimulators demand, (USD Million), 2012 - 2020 3.2.1.12. Global Exoskeletons demand, (USD Million), 2012 - 2020 3.2.1.13. Global Bionic limbs demand, (USD Million), 2012 - 2020 3.2.1.14. Global Bionic hands demand, (USD Million), 2012 - 2020 3.2.1.15. Global Bionic legs demand, (USD Million), 2012 - 2020 3.2.1.16. Global Vision bionics demand, (USD Million), 2012 - 2020 Chapter 4. Artificial Organ Technology Outlook 4.1. Mechanical bionics 4.1.1. Global mechanical bionic demand, (USD Million), 2012 - 2020 4.2. Electronic bionics 4.2.1. Global electronic demand, (USD Million), 2012 - 2020 Chapter 5. Artificial organ Regional Outlook 5.1. North America 5.1.1. North America artificial organmarket revenue by product, (USD Million), 2012 - 2020 5.1.2. North America artificial organmarket revenue by technology, (USD Million), 2012 - 2020 5.2. Europe 5.2.1. Europe artificial organmarket revenue by product, (USD Million), 2012 - 2020 5.2.2. Europe artificial organmarket revenue by technology, (USD Million), 2012 - 2020 5.3. Asia Pacific 5.3.1. Asia Pacific artificial organmarket revenue by product, (USD Million), 2012 - 2020 5.3.2. Asia Pacific artificial organmarket revenue by product technology, (USD Million), 2012 - 2020 5.4. RoW 5.4.1. RoW artificial organmarket revenue by product, (USD Million), 2012 - 2020 5.4.2. RoW artificial organmarket revenue by product technology, (USD Million), 2012 - 2020 Chapter 6 Competitive Landscape 6.1 Abiomed Inc. 6.1.1 Company Overview 6.1.2 Financial Performance 6.1.3 Product Benchmarking 6.1.4 Strategic Initiatives 6.2 Asahi Kasei Kuraray Medical Co. Ltd. 6.2.1 Company Overview 6.2.2 Financial Performance 6.2.3 Product Benchmarking 6.2.4 Strategic Initiatives 6.3 Thoratec Corporation 6.3.1 Company Overview 6.3.2 Financial Performance 6.3.3 Product Benchmarking 6.3.4 Strategic Initiatives 6.4 WorldHeart Corp. 6.4.1 Company Overview 6.4.2 Financial Performance 6.4.3 Product Benchmarking 6.4.4 Strategic Initiatives 6.5 Gambro AB 6.5.1 Company Overview 6.5.2 Financial Performance 6.5.3 Product Benchmarking 6.5.4 Strategic Initiatives 6.6 Biomet Inc. 6.6.1 Company Overview 6.6.2 Financial Performance 6.6.3 Product Benchmarking 6.6.4 Strategic Initiatives 6.7 Cochlear Ltd 6.7.1 Company Overview 6.7.2 Financial Performance 6.7.3 Product Benchmarking 6.7.4 Strategic Initiatives 6.8 Berlin Heart Gmbh 6.8.1 Company Overview 6.8.2 Financial Performance 6.8.3 Product Benchmarking 6.8.4 Strategic Initiatives 6.9 Ekso Bionics 6.9.1 Company Overview 6.9.2 Financial Performance 6.9.3 Product Benchmarking 6.9.4 Strategic Initiatives 6.10 Medtronic Inc. 6.10.1 Company Overview 6.10.2 Financial Performance 6.10.3 Product Benchmarking 6.10.4 Strategic Initiatives 6.11 Lifenet Health 6.11.1 Company Overview 6.11.2 Financial Performance 6.11.3 Product Benchmarking 6.11.4 Strategic Initiatives 6.12 Heartware International Inc. 6.12.1 Company Overview 6.12.2 Financial Performance 6.12.3 Product Benchmarking 6.12.4 Strategic Initiatives 6.13 Jarvik Heart Inc. 6.13.1 Company Overview 6.13.2 Financial Performance 6.13.3 Product Benchmarking 6.13.4 Strategic Initiatives 6.14 Walk Inc.Ossur 6.14.1 Company Overview 6.14.2 Financial Performance 6.14.3 Product Benchmarking 6.14.4 Strategic Initiatives 6.15 Boston Scientific Corporation 6.15.1 Company Overview 6.15.2 Financial Performance 6.15.3 Product Benchmarking 6.15.4 Strategic Initiatives 6.16 Sorin S.P.A. 6.16.1 Company Overview 6.16.2 Financial Performance 6.16.3 Product Benchmarking 6.16.4 Strategic Initiatives Chapter 7 Methodology and Scope 7.1 Research Methodology 7.2 Research Scope & Assumptions 7.3 List of Data Sources List of Tables Artificial organ and medical bionics - Industry Summary & Critical Success Factors (CSFs) Global artificial organ and medical bionics market share (USD Million), 2013 & 2020 Global artificial organ market by product (USD Million), 2012 - 2020 Global total artificial heart market (USD Million), 2012 - 2020 Global artificial liver market (USD Million), 2012 - 2020 Global artificial pancreas market (USD Million), 2012 - 2020 Global artificial lungs market (USD Million), 2012 - 2020 Global artificial kidney market (USD Million), 2012 - 2020 Global bionics market by product (USD Million), 2012 - 2020 Global cochlear implants market (USD Million), 2012 - 2020 Global cardiac bionics market by product (USD Million), 2012 - 2020 Global heart valvesmarket by product(USD Million), 2012 - 2020 Global mechanical valves market (USD Million), 2012 - 2020 Global transcatheter heart valve market (USD Million), 2012 - 2020 Global ventricular assist device market (USD Million), 2012 - 2020 Global Bionic limbs market by product (USD Million), 2012 - 2020 Global bionic legs market (USD Million), 2012 - 2020 Global bionic hands market (USD Million), 2012 - 2020 Global brain bionic market by product(USD Million), 2012 - 2020 Global deep brain stimulators market (USD Million), 2012 - 2020 Global spinal cord stimulators market (USD Million), 2012 - 2020 Global vagus nerves stimulators market (USD Million), 2012 - 2020 Global vision bionics market (USD Million), 2012 - 2020 Global artificial organ market by technology (USD Million), 2013 & 2020 Global mechanical bionics market (USD Million), 2012 - 2020 Global mechanical bionics market (USD Million), 2012 - 2020 Global electronic bionics market (USD Million), 2012 - 2020 North America artificial organmarket by product (USD Million), 22012 - 2020 Europe artificial organmarket by product (USD Million), 2012 - 2020 Asia Pacific artificial organmarket by product (USD Million), 2012 - 2020 RoW artificial organmarket by product (USD Million), 2012 - 2020 List of Figures Artificial organ Market Segmentation Global artificial organ and medical bionics market (USD Million), 2012 - 2020 Artificial organvalue chain analysis Artificial organand medical bionics market dynamics Artificial organ- Company market share analysis, 2013 Key Opportunities Prioritized Industry Analysis - Porter's Artificial organ PESTEL Analysis, 2013 Artificial organ and bionic market share by product, 2012 - 2020 Artificial organ and bionic market share by technology, 2012 - 2020 Artificial organ and bionic market share by region, 2012 - 2020 North America artificial organand bionic market, by product (USD Million), 2012 - 2020 North America artificial organ and bionicmarket, by technology (USD Million), 2012 - 2020 Europe artificial organ and bionic market, by product (USD Million), 2012 - 2020 Europe artificial organand bionic market, by technology (USD Million), 2012 - 2020 Asia Pacific artificial organ and bionicmarket, by product (USD Million), 2012 - 2020 Asia Pacific artificial organ and bionicmarket, by technology (USD Million), 2012 - 2020 RoW artificial organ and bionic market, by product (USD Million), 2012 - 2020 RoW artificial organand bionic market, by technology (USD Million), 2012 - 2020
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
